Evaluating the effects of carbidopa/levodopa/entacapone on motor function and quality of life in patients with Parkinson's disease

Trial Profile

Evaluating the effects of carbidopa/levodopa/entacapone on motor function and quality of life in patients with Parkinson's disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Levodopa/carbidopa/entacapone (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 02 May 2009 Primary endpoint results presented at the 61st Annual Meeting of the American Academy of Neurology
    • 18 Jul 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
    • 10 Jun 2008 Status change from recruiting to in progress, according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top